Müeloomtõbi Diagnoosimis- ja ravijuhis
Combination therapy with thalidomide plus dexamethazone for newly diagnosed
myeloma. J Clin Oncol (2002) 20: 4319-23
13) Weber D, Rankin K, Gavino M, Delasalle K, Alexanian R. Thalidomide alone or
with dexamethazone for previously untreated multiple myeloma. J clin Oncol
(2003) 21: 16-19
14) Tricot G. Treatment advances in multiple myeloma, British Journal of
Haematology, 125, 24-30.
-43-
15) Barlogie B, Desican R, Eddelmon P. Extended survival in advanced and refractory
multiple myeloma after single-agent thalidomide: identification of prognostic
factors in a phase 2 study of 169 patients, Blood (2001) 98: 492-494.
16) Heinz L et al. Management of disease-related anemia in patients with multiple
myeloma or chronic lymphocytic leukemia: epoetin treatment recommendations,
the Hematology Journal (2002) 3: 121-130
17) Richardson P et al
annaabi.ee 
